Acute Myocardial Infarction
Adjunctive intravenous adenosine improves microvascular reflow after primary coronary stenting
Published in Cardiovascular Week, January 30th, 2006
In a recent study from the United States, "30 patients who underwent primary PCS for acute myocardial infarction were randomized to intravenous adenosine (50 to 70 microg/kg/min) or vehicle for 3 hours."
"Myocardial contrast echocardiography was performed before and sequentially after PCS to determine the risk area during coronary occlusion and infarct size," explained A. Micari and coauthors at the University of Virginia. They found that the "risk area was similar in the adenosine- and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2006-01-30)
More Articles from Cardiovascular Week
- Atherosclerosis
Fas ligand gene transfer increases vulnerability of atherosclerosis - Atherosclerosis
MCP-1 and eotaxin levels are not indicators of atherosclerosis or myocardial infarction - Coronary Artery Disease
Base serum levels of inflammatory markers may be influenced by endogenous sex hormones - Pediatric Cardiology
Acetyl-L-carnitine may exert cardiac neurotrophic action - Statins
IB ultrasound indicates fluvastatin improved arterial sclerosis - Adverse Events
Medication with beta-blocker help prevent ICD shocks - More from this issue of Cardiovascular Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
